Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ALNY | ALNYLAM PHARMACEUTICALS, INC. | EVP, Chief Financial Officer | $7.41 M | -$1.25 M | -14.5% | Jun 24, 2024 |
CRVO | CervoMed Inc. | Director | Jun 14, 2024 | |||
FIXX | Q32 Bio Inc. | Director | Jun 14, 2023 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|